Biotrial

Biotrial's Biometrics and Clinical teams work together to implement comprehensive RTSM solutions, including for complex randomization and drug supply projects. Cross-functional collaboration is at the heart of our success for such projects, where our clinical operations, data management and biostatistics expertise come together to design Central Randomization and Drug Supply solutions, which align seamlessly with sponsor protocols.  Our joint expertise in Biometrics and Clinical research ensures: ✅User friendliness for investigator site teams ✅Operational efficiency  ✅Trial executed as designed  #Clinicaltrials #dataintegrity #RTSM

Electronic patient-reported outcomes (ePRO) are essential for collecting accurate and reliable data in #clinicaltrials. At Biotrial, we use a variety of ePRO solutions to collect patient data, including questionnaires, Visual Analog Scales (VAS), diaries and clinical assessments. ePRO protects data accuracy in a number of ways : ☑️Real-time data collection ☑️Data validation ☑️Data encryption We work with our partners to select the most appropriate ePRO technology for each clinical trial, based on the specific needs of the study and the patient population. #ClinicalResearch #Innovation

New behavioral preclinical readouts for cognition assessment at Biotrial! We are excited to announce the upcoming implementation of two behavioral tests, the Barnes Maze and Y Maze, aimed at evaluating cognitive abilities such as learning and memory in animals across various pathological contexts (Schizophrenia, Alzheimer’s disease, mild cognitive impairment). Our advanced methodologies will include cognitive performance analysis, movement tracking, speed,and areas investigated. Contact us for more information at contact@biotrial.com #preclinical #cognition #neurosciences

At Biotrial, we understand that a seamless onboarding process sets the stage for long-term success and fosters a sense of belonging and collaboration for new employees. That’s why we ensure that new hires receive a thorough introduction to our company's various services with a comprehensive onboarding program. By providing new employees with the opportunity to connect with experts in different fields and gain a deeper understanding of our services, we cultivate a strong sense of team spirit and collaboration. This integration not only helps individuals acclimate to their roles but also encourages cross-departmental cooperation, fueling innovation and enhancing the overall effectiveness of our teams.    #EmployeeIntegration #CompanyCulture #onboarding #teamwork 

Once a month, Biotrial's Bioanalysis team in Canada enjoys a special breakfast together. 🥐☕️ These mornings boost team cohesion, foster open communication, and provide a relaxed space to share ideas! #Teamspirit #Bioanalysis #Workplaceculture

We are thrilled to announce that our Chief Operating Officer, Nicolas Fauchoux, has been recognized as one of the Top 50 COOs globally at the OnCon Icon Awards. This prestigious honor underscores his significant contributions to clinical research and leadership excellence. Join us in congratulating Nicolas on this remarkable achievement. 👉 Discover more about his journey and Biotrial’s dedication to innovation in clinical research: https://lnkd.in/eTvSXMPR  #Leadership #Innovation #Clinicalresearch #TopCOO

#Psychedelics have fascinated us for centuries with their mind-altering properties. Today, they're captivating the world of neuropsychiatric research as a potential solution for conditions like depression, PTSD, and addiction. 👉Read our latest article about the crucial role of preclinical studies in uncovering the therapeutic potential of psychedelics for these disorders. Leveraging Biotrial's translational expertise ensures a seamless transition from preclinical research to clinical application, enhancing the development of effective treatments: https://lnkd.in/eTzAUXm5 #Neuropsychiatry #Preclinical

Biotrial is proud to have contributed to a groundbreaking clinical study! The research, titled "Pharmacodynamics of Multiple Ascending Oral Doses of ALG-055009, a THR-β Agonist, in Hyperlipidemic Subjects" in collaboration with Aligos Therapeutics, demonstrates significant reductions in LDL-C, apolipoprotein-B, VLDL, and triglycerides, showcasing the potential of ALG-055009 in treating hyperlipidemia with a favorable safety profile. A big thank you to all involved! 👉 Download the study: https://lnkd.in/g4T58_dB  #clinicalresearch

Unlocking the mysteries of molecules!  Biotrial's Bioanalysis team is pioneering innovative methods in 80% of our studies, using LC-MS/MS and diverse biofluids to analyze drugs, metabolites, and more. 👇Explore the infographic to see how we're driving scientific progress. #Bioanalysis #Bioanalytical 

Biotrial is proud to have contributed to a groundbreaking preclinical study published in PLOS ONE! The study, titled "Afatinib or Bevacizumab in combination with Osimertinib efficiently controls tumor development in orthotopic murine models of non-small lung cancer," is a result of a successful collaborative project through our common laboratory #Oncotrial with Remy Pedeux's team (OSS U1242) and Ulrich Jarry. This research highlights effective new therapies for EGFR-mutated lung cancer using advanced mouse models. A big thank you to all the partners involved! 👉 Download the study: https://lnkd.in/g4T58_dB #Oncotrial #Lungcancerresearch #Preclinicalstudy